Ovarian Cancer Publication 2026

When cancer treatment decisions are being discussed, patients and care teams often want as much useful information as possible. This video explains how functional testing studies live tumor cells in the laboratory to see how they respond to selected cancer therapies, adding information that may support physician guided treatment planning. The SAGE Oncotest is available for all solid tumor cancer patients.

SAGE Oncotest Reveal™ showed marked differences in ovarian cancer drug response using viable patient-derived 3D microtumors. Among 17 specimens, responses to NCCN-recommended therapies varied widely, especially for carboplatin/paclitaxel. Some tumors with reduced response to standard platinum-taxane therapy showed greater sensitivity to alternatives such as gemcitabine or doxorubicin.